New Bioionix Patent Issues
The U.S. Patent and Trademark office today issued Bioionix, Inc.'s fifth patent. The 19 claims of this new patent protect the company's unique design of catalytic reactor module that offers significant competitive advantages in the market. These include cost-effective methods of liquid pressure control and the ability to meet customer-specific flow rate requirements from standard modular components. The design also meets USDA, FDA and other regulatory requirements while fully adhering to food industry cleanability and sanitation standards.